메뉴 건너뛰기




Volumn 210, Issue 3, 2013, Pages 745-750

Cost analysis of risperidone long-acting injection in the treatment of schizophrenia and schizoaffective disorders in Hong Kong: An approach using generalised estimating equations

Author keywords

Generalised estimating equations; Mirror image analysis; Risperidone long acting injection (RLAI)

Indexed keywords

LONG ACTING DRUG; NEUROLEPTIC AGENT; RISPERIDONE; DELAYED RELEASE FORMULATION;

EID: 84888287588     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2013.07.012     Document Type: Article
Times cited : (9)

References (26)
  • 1
    • 0025942542 scopus 로고
    • Assessment issues and the cost of schizophrenia
    • Andreasen N.C. Assessment issues and the cost of schizophrenia. Schizophrenia Bulletin 1991, 17(3):475-481.
    • (1991) Schizophrenia Bulletin , vol.17 , Issue.3 , pp. 475-481
    • Andreasen, N.C.1
  • 2
    • 0032526166 scopus 로고    scopus 로고
    • Extending the simple linear regression model to account for correlated responses: an introduction to generalized estimating equations and multi-level mixed modelling
    • Burton P., Gurrin L., Sly P. Extending the simple linear regression model to account for correlated responses: an introduction to generalized estimating equations and multi-level mixed modelling. Statistics in Medicine 1998, 17:1261-1291.
    • (1998) Statistics in Medicine , vol.17 , pp. 1261-1291
    • Burton, P.1    Gurrin, L.2    Sly, P.3
  • 3
    • 77956475205 scopus 로고    scopus 로고
    • Comparative effectiveness of long-acting risperidone in New Zealand: a report of resource utilization and costs in a 12-month mirror-image analysis
    • Carswell C., Wheeler A., Vanderpyl J., Robinson E. Comparative effectiveness of long-acting risperidone in New Zealand: a report of resource utilization and costs in a 12-month mirror-image analysis. Clinical Drug Investigation 2010, 30(11):777-787.
    • (2010) Clinical Drug Investigation , vol.30 , Issue.11 , pp. 777-787
    • Carswell, C.1    Wheeler, A.2    Vanderpyl, J.3    Robinson, E.4
  • 4
    • 0031916292 scopus 로고    scopus 로고
    • Compliance with medication regimens for mental and physical disorders
    • Cramer J., Rosenheck R. Compliance with medication regimens for mental and physical disorders. Psychiatric Services 1998, 49(2):196-201.
    • (1998) Psychiatric Services , vol.49 , Issue.2 , pp. 196-201
    • Cramer, J.1    Rosenheck, R.2
  • 5
    • 60349125075 scopus 로고    scopus 로고
    • Long-acting injectable risperidone and hospital readmission: a mirror-image study using a national claim-based database in Taiwan
    • Chang H.C., Tang C.H., Tsai S.J., Yen F.C., Su K.P. Long-acting injectable risperidone and hospital readmission: a mirror-image study using a national claim-based database in Taiwan. The Journal of Clinical Psychiatry 2009, 70(1):141.
    • (2009) The Journal of Clinical Psychiatry , vol.70 , Issue.1 , pp. 141
    • Chang, H.C.1    Tang, C.H.2    Tsai, S.J.3    Yen, F.C.4    Su, K.P.5
  • 7
    • 0037012134 scopus 로고    scopus 로고
    • A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia
    • Csernansky J.G., Mahmoud R., Brenner R. A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia. New England Journal of Medicine 2002, 346:16-22.
    • (2002) New England Journal of Medicine , vol.346 , pp. 16-22
    • Csernansky, J.G.1    Mahmoud, R.2    Brenner, R.3
  • 8
    • 0015170072 scopus 로고
    • The contribution of fluphenazine enanthate and decanoate in the prevention of readmission of schizophrenic patients
    • Denham J., Adamson L. The contribution of fluphenazine enanthate and decanoate in the prevention of readmission of schizophrenic patients. Acta Psychiatrica Scandinavica 1971, 47(4):420-430.
    • (1971) Acta Psychiatrica Scandinavica , vol.47 , Issue.4 , pp. 420-430
    • Denham, J.1    Adamson, L.2
  • 10
    • 0344429683 scopus 로고    scopus 로고
    • Treatment of schizophrenia with long-acting injectable risperidone: a 12-month open-label trial of the first long-acting second-generation antipsychotic
    • Fleischhacker W.W., Eerdekens M., Karcher K., Remington G., Llorca P.M., Chrzanowski W., Gefvert O. Treatment of schizophrenia with long-acting injectable risperidone: a 12-month open-label trial of the first long-acting second-generation antipsychotic. The Journal of Clinical Psychiatry 2003, 64:1250-1257.
    • (2003) The Journal of Clinical Psychiatry , vol.64 , pp. 1250-1257
    • Fleischhacker, W.W.1    Eerdekens, M.2    Karcher, K.3    Remington, G.4    Llorca, P.M.5    Chrzanowski, W.6    Gefvert, O.7
  • 12
    • 0030761817 scopus 로고    scopus 로고
    • Pharmacoeconomic evaluation of antipsychotic therapy for schizophrenia
    • Glazer W., Johnstone B.M. Pharmacoeconomic evaluation of antipsychotic therapy for schizophrenia. The Journal of Clinical Psychiatry 1997, 58(suppl. 10):50-54.
    • (1997) The Journal of Clinical Psychiatry , vol.58 , Issue.SUPPL. 10 , pp. 50-54
    • Glazer, W.1    Johnstone, B.M.2
  • 13
    • 33644829405 scopus 로고    scopus 로고
    • Pharmacoeconomics of long-acting risperidone: results and validity of cost-effectiveness models
    • (Review)
    • Haycox A. Pharmacoeconomics of long-acting risperidone: results and validity of cost-effectiveness models. Pharmacoeconomics 2005, 23(Suppl 1):3-16. (Review).
    • (2005) Pharmacoeconomics , vol.23 , Issue.SUPPL 1 , pp. 3-16
    • Haycox, A.1
  • 14
    • 0034352084 scopus 로고    scopus 로고
    • Schizophrenia costs and treatment cost-effectiveness
    • Knapp M. Schizophrenia costs and treatment cost-effectiveness. Acta Psychiatrica Scandinavica 2000, 102:S15-S18.
    • (2000) Acta Psychiatrica Scandinavica , vol.102
    • Knapp, M.1
  • 15
    • 84858734196 scopus 로고    scopus 로고
    • Long acting risperidone in Australian patients with chronic schizophrenia: 24-month data from the e-STAR database
    • Lambert T., Emmerson B., Hustig H., Resseler S., Jacobs A., Butcher B. Long acting risperidone in Australian patients with chronic schizophrenia: 24-month data from the e-STAR database. BMC Psychiatry 2012, 12(1):25.
    • (2012) BMC Psychiatry , vol.12 , Issue.1 , pp. 25
    • Lambert, T.1    Emmerson, B.2    Hustig, H.3    Resseler, S.4    Jacobs, A.5    Butcher, B.6
  • 16
    • 73449130028 scopus 로고    scopus 로고
    • Effectiveness of a psychosocial intervention for relapse prevention in patients with schizophrenia receiving risperidone via long-acting injection
    • Lee S.H., Choi T.K., Suh S., Kim Y.W. Effectiveness of a psychosocial intervention for relapse prevention in patients with schizophrenia receiving risperidone via long-acting injection. Psychiatry Research 2010, 175(3):195-199.
    • (2010) Psychiatry Research , vol.175 , Issue.3 , pp. 195-199
    • Lee, S.H.1    Choi, T.K.2    Suh, S.3    Kim, Y.W.4
  • 17
    • 0042978712 scopus 로고    scopus 로고
    • Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials
    • Leucht S., Barnes T.R., Kissling W., Engel R.R., Correll C., Kane J.M. Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials. American Journal of Psychiatry 2003, 160:1209-1222.
    • (2003) American Journal of Psychiatry , vol.160 , pp. 1209-1222
    • Leucht, S.1    Barnes, T.R.2    Kissling, W.3    Engel, R.R.4    Correll, C.5    Kane, J.M.6
  • 18
    • 77649173768 scopus 로고
    • Longitudinal data analysis using generalized linear models
    • Liang K.Y., Zeger S. Longitudinal data analysis using generalized linear models. Biometrika 1986, 73(1):13-22.
    • (1986) Biometrika , vol.73 , Issue.1 , pp. 13-22
    • Liang, K.Y.1    Zeger, S.2
  • 21
    • 84888297396 scopus 로고    scopus 로고
    • National Institute for Clinical Excellence. Guidance on the use of newer (atypical) antipsychotic drugs for the prevention of relapse in patients with schizophrenia [online].Retrieved from:.
    • National Institute for Clinical Excellence., 2011. Guidance on the use of newer (atypical) antipsychotic drugs for the prevention of relapse in patients with schizophrenia [online].Retrieved from:. http://guidance.nice.org.uk/TA43.
    • (2011)
  • 22
    • 34250005736 scopus 로고    scopus 로고
    • Thirty-five months experience of risperidone long-acting injection in a UK psychiatric service including a mirror-image analysis of in-patient care
    • Niaz O.S., Haddad P.M. Thirty-five months experience of risperidone long-acting injection in a UK psychiatric service including a mirror-image analysis of in-patient care. Acta Psychiatrica Scandinavica 2007, 116:36-46.
    • (2007) Acta Psychiatrica Scandinavica , vol.116 , pp. 36-46
    • Niaz, O.S.1    Haddad, P.M.2
  • 23
    • 0017069599 scopus 로고
    • Fluphenazine decanoate maintenance in schizophrenia: a retrospective study
    • Polonowita A., James N.M. Fluphenazine decanoate maintenance in schizophrenia: a retrospective study. The New Zealand Medical Journal 1976, 83:316-318.
    • (1976) The New Zealand Medical Journal , vol.83 , pp. 316-318
    • Polonowita, A.1    James, N.M.2
  • 24
    • 0346753734 scopus 로고    scopus 로고
    • Relapse and rehospitalization: Comparing oral and depot antipsychotics
    • Schooler N. Relapse and rehospitalization: Comparing oral and depot antipsychotics. The Journal of Clinical Psychiatry 2003, 64(Suppl 16):14-17.
    • (2003) The Journal of Clinical Psychiatry , vol.64 , Issue.SUPPL 16 , pp. 14-17
    • Schooler, N.1
  • 26
    • 72149124211 scopus 로고    scopus 로고
    • Cost-Effectiveness of Long-Acting Risperidone Injection versus Alternative Atypical Antipsychotic Agents in Patients with Schizophrenia in China
    • Yang L., Li M., Tao L.B., Zhang M., Nicholl M.D., Dong P. Cost-Effectiveness of Long-Acting Risperidone Injection versus Alternative Atypical Antipsychotic Agents in Patients with Schizophrenia in China. Value in health 2009, 12(s3):66-69.
    • (2009) Value in health , vol.12 , Issue.3 S , pp. 66-69
    • Yang, L.1    Li, M.2    Tao, L.B.3    Zhang, M.4    Nicholl, M.D.5    Dong, P.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.